ArticleFrontiers in pharmacology2022

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.